{"id":"https://openalex.org/W1985367536","doi":"https://doi.org/10.1016/j.vascn.2013.01.166","title":"Electromyographic telemetry monitoring of SXN101959, a targeted secretion inhibitor (TSI) in the Sprague\u2013Dawley rat","display_name":"Electromyographic telemetry monitoring of SXN101959, a targeted secretion inhibitor (TSI) in the Sprague\u2013Dawley rat","publication_year":2013,"publication_date":"2013-07-01","ids":{"openalex":"https://openalex.org/W1985367536","doi":"https://doi.org/10.1016/j.vascn.2013.01.166","mag":"1985367536"},"language":"en","primary_location":{"id":"doi:10.1016/j.vascn.2013.01.166","doi":"https://doi.org/10.1016/j.vascn.2013.01.166","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.vascn.2013.01.166","pdf_url":null,"source":{"id":"https://openalex.org/S89571363","display_name":"Journal of Pharmacological and Toxicological Methods","issn_l":"1056-8719","issn":["1056-8719","1873-488X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacological and Toxicological Methods","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111747784","display_name":"St\u00e9phane P. Milano","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephane Milano","raw_affiliation_strings":["Ricerca Biosciences SAS, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ricerca Biosciences SAS, Lyon, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075536042","display_name":"Christophe Bory","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christophe Bory","raw_affiliation_strings":["Ricerca Biosciences SAS, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ricerca Biosciences SAS, Lyon, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110290256","display_name":"C\u00e9line Dupuis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Celine Dupuis","raw_affiliation_strings":["Ricerca Biosciences SAS, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ricerca Biosciences SAS, Lyon, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004921857","display_name":"Estelle Chalencon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Estelle Chalencon","raw_affiliation_strings":["Ricerca Biosciences SAS, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ricerca Biosciences SAS, Lyon, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Richard Jones","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard Jones","raw_affiliation_strings":["Syntaxin LTD, Abingdon, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Syntaxin LTD, Abingdon, UK","institution_ids":[]}]},{"author_position":"last","author":{"id":null,"display_name":"Alberto Martinez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alberto Martinez","raw_affiliation_strings":["Syntaxin LTD, Abingdon, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Syntaxin LTD, Abingdon, UK","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3500,"currency":"USD","value_usd":3500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.08622734,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"68","issue":"1","first_page":"e46","last_page":"e46"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T14072","display_name":"Immunotoxicology and immune responses","score":0.45649999380111694,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T14072","display_name":"Immunotoxicology and immune responses","score":0.45649999380111694,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10441","display_name":"Muscle Physiology and Disorders","score":0.14509999752044678,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11274","display_name":"Botulinum Toxin and Related Neurological Disorders","score":0.05420000106096268,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.3619999885559082},{"id":"https://openalex.org/keywords/muscle-function","display_name":"muscle function","score":0.38999998569488525},{"id":"https://openalex.org/keywords/sprague-dawley-rats","display_name":"Sprague-Dawley rats","score":0.7720000147819519},{"id":"https://openalex.org/keywords/drug-induced-myopathy","display_name":"drug-induced myopathy","score":0.4180000126361847}],"concepts":[{"id":"https://openalex.org/C183121708","wikidata":"https://www.wikidata.org/wiki/Q209867","display_name":"Telemetry","level":2,"score":0.9140990972518921},{"id":"https://openalex.org/C49039625","wikidata":"https://www.wikidata.org/wiki/Q84230","display_name":"Secretion","level":2,"score":0.5692295432090759},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3867134749889374},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3475660979747772},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3252961337566376},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.29753953218460083},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.08246779441833496},{"id":"https://openalex.org/C76155785","wikidata":"https://www.wikidata.org/wiki/Q418","display_name":"Telecommunications","level":1,"score":0.06411901116371155}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.vascn.2013.01.166","doi":"https://doi.org/10.1016/j.vascn.2013.01.166","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.vascn.2013.01.166","pdf_url":null,"source":{"id":"https://openalex.org/S89571363","display_name":"Journal of Pharmacological and Toxicological Methods","issn_l":"1056-8719","issn":["1056-8719","1873-488X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacological and Toxicological Methods","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.5683000087738037}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2319016959","https://openalex.org/W7067831780","https://openalex.org/W2953124701","https://openalex.org/W2411454713","https://openalex.org/W2073609792","https://openalex.org/W2890289701","https://openalex.org/W2412730625","https://openalex.org/W1979262573","https://openalex.org/W2024300949","https://openalex.org/W2409549925"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}